Washington weighs a harder bargain for Israel’s next defense aid pact

Washington weighs a harder bargain for Israel’s next defense aid pact

Washington is moving toward an early fight over the post-2028 US-Israel defense aid framework, with the current $38 billion memorandum set to expire after fiscal 2028. The debate is sharpening after recent Iranian missile attacks required heavy US military support for Israel, putting interceptor supply and industrial capacity back at the center of the alliance.

United States

The immediate issue is not whether the United States will remain Israel’s main security partner. It is whether the next long-term agreement should look like the current one, or whether the White House, Pentagon and Congress will press Israel to assume more of the production and funding burden for air and missile defense.

The existing 10-year Memorandum of Understanding was signed in 2016 during the Obama administration and provides $38 billion in US security assistance through fiscal 2028. Its structure matters in Washington because it phased out Israel’s Offshore Procurement allowance, which had let Israel spend part of the aid in its own defense industry, and moved the money toward purchases from the US defense industrial base.

That design reflected a bargain: Israel received a predictable annual security package, while US defense firms captured more of the procurement. For Capitol Hill, it also made the aid easier to defend as both a foreign policy commitment and an industrial policy instrument supporting American weapons production.

Recent operations involving US air defense assets

The problem now is capacity. Recent operations involving US air defense assets, naval forces and interceptor stocks have put a harsher question before Pentagon planners: how much scarce ammunition Washington can spend in the Middle East while preserving reserves for other theaters, including the Indo-Pacific.

Israel’s missile defense network depends on layered systems, including Iron Dome for shorter-range rockets and Arrow for ballistic missile threats. The United States has supported that architecture for years through funding, joint development and emergency resupply, but the scale of Iranian fire has made replenishment speed a strategic issue rather than a budget footnote.

Inside Washington, that creates an unusual coalition of pressure. Defense hawks want more joint production so the United States and Israel can increase interceptor output. Fiscal conservatives want clearer burden-sharing. Some Democrats want stronger conditions on military aid, particularly after the Gaza war made Israel policy one of the most divisive issues in the party.

The White House sits between those pressures. It has an interest in preserving Israel’s qualitative military edge and deterring Iran, but it also has to manage US force readiness, congressional scrutiny and an electorate less willing to treat foreign military aid as automatic.

For the Pentagon, the narrow question is stockpiles. If US commanders must deploy THAAD batteries, Aegis ships, SM-3 interceptors or other high-demand assets during repeated regional crises, the strain can move quickly from emergency support to readiness trade-off.

For Congress, the broader question is leverage. A new MOU would give lawmakers and the administration a rare chance to rewrite the terms of a relationship usually handled through annual appropriations, supplemental packages and crisis-driven arms transfers.

That is why the post-2028 agreement is likely to be about production as much as politics. A straight continuation of the $3.8 billion annual model would reassure Israel and its supporters, but it would do less to answer the industrial bottleneck exposed by repeated missile and drone threats.

A restructured pact could require expanded co-production of interceptors, clearer Israeli co-funding, or procurement rules that protect US inventories during simultaneous crises. Each option carries costs: more conditions could strain Israeli confidence, while fewer conditions could leave Washington underwriting a defense burden it may not be able to sustain during a larger conflict.

The politics are also shifting. Support for Israel remains strong across much of Congress, but the consensus is no longer as insulated as it was when the 2016 MOU was negotiated. Progressive lawmakers have pushed for aid restrictions, while Republican defense hawks have tended to frame the issue around Iran deterrence and weapons output rather than humanitarian conditions.

That divide gives the defense industry a central role. If lawmakers settle on co-production, companies that build interceptors, radar components, rocket motors and naval munitions would become part of the policy architecture, not merely vendors downstream from it.

The Israeli government’s risk is dependence. If US emergency support becomes harder to guarantee in a multi-theater crisis, Israel would need deeper domestic production and more resilient supply chains.

If the United States continues to provide large-scale support without new conditions, Israel may preserve flexibility but remain exposed to future US political and inventory constraints.

The global macro effect would come through defense spending and regional risk. If Washington requires more co-production, the result could mean higher near-term capital spending in the US and Israeli defense sectors, but also a clearer production pipeline for missile defense.

If the current model rolls forward, the alliance remains simpler politically in the short run, while leaving unresolved the question of how many interceptors Washington can spare during overlapping crises.

The falsifiable test is whether the House Armed Services Committee or the Senate Foreign Relations Committee formalizes bipartisan language on the next US-Israel defense memorandum or interceptor co-production requirements by May 15, 2025. The restructuring thesis is right if congressional leaders or State Department officials back draft language requiring more Israeli co-funding and US co-production under any post-2028 MOU; it is wrong if the White House publicly commits to a straight rollover of the current $3.8 billion annual grant model without new industrial or stockpile-sharing mandates.